Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Accumulated Expenses: 2022-2023

  • Lexeo Therapeutics' Accumulated Expenses was N/A to $11.8 million in Q3 2023 from the same period last year, while for Sep 2023 it was $11.8 million, marking a year-over-year change of. This contributed to the annual value of $6.4 million for FY2022, which is N/A change from last year.
  • Per Lexeo Therapeutics' latest filing, its Accumulated Expenses stood at $11.8 million for Q3 2023, which was up 83.86% from $6.4 million recorded in Q4 2022.
  • In the past 5 years, Lexeo Therapeutics' Accumulated Expenses ranged from a high of $11.8 million in Q3 2023 and a low of $6.4 million during Q4 2022.
  • For the 2-year period, Lexeo Therapeutics' Accumulated Expenses averaged around $9.1 million, with its median value being $9.1 million (2022).